• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢相关性脂肪性肝病中自噬失调:一个新的治疗靶点。

Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target.

机构信息

Department of Pediatrics, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan.

School of Medicine, National Yang Ming Chiao Tung University, Taipei City 112, Taiwan.

出版信息

Int J Mol Sci. 2022 Sep 2;23(17):10055. doi: 10.3390/ijms231710055.

DOI:10.3390/ijms231710055
PMID:36077452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9456355/
Abstract

Metabolic associated fatty liver disease (MAFLD) is one of the most common causes of chronic liver disease worldwide. To date, there is no FDA-approved treatment, so there is an urgent need to determine its pathophysiology and underlying molecular mechanisms. Autophagy is a lysosomal degradation pathway that removes damaged organelles and misfolded proteins after cell injury through endoplasmic reticulum stress or starvation, which inhibits apoptosis and promotes cell survival. Recent studies have shown that autophagy plays an important role in removing lipid droplets from hepatocytes. Autophagy has also been reported to inhibit the production of pro-inflammatory cytokines and provide energy for the hepatic stellate cells activation during liver fibrosis. Thyroid hormone, irisin, melatonin, hydrogen sulfide, sulforaphane, DA-1241, vacuole membrane protein 1, nuclear factor erythroid 2-related factor 2, sodium-glucose co-transporter type-2 inhibitors, immunity-related GTPase M, and autophagy-related gene 7 have been reported to ameliorate MAFLD via autophagic induction. Lipid receptor CD36, SARS-CoV-2 Spike protein and leucine aminopeptidase 3 play a negative role in the autophagic function. This review summarizes recent advances in the role of autophagy in MAFLD. Autophagy modulates major pathological changes, including hepatic lipid metabolism, inflammation, and fibrosis, suggesting the potential of modulating autophagy for the treatment of MAFLD.

摘要

代谢相关性脂肪性肝病(MAFLD)是全球最常见的慢性肝病病因之一。迄今为止,尚无获得美国食品和药物管理局(FDA)批准的治疗方法,因此迫切需要确定其病理生理学和潜在的分子机制。自噬是一种溶酶体降解途径,可在细胞损伤后通过内质网应激或饥饿清除受损的细胞器和错误折叠的蛋白质,从而抑制细胞凋亡并促进细胞存活。最近的研究表明,自噬在从肝细胞中清除脂滴方面起着重要作用。自噬还被报道可抑制促炎细胞因子的产生,并在肝纤维化过程中为肝星状细胞激活提供能量。甲状腺激素、鸢尾素、褪黑素、硫化氢、萝卜硫素、DA-1241、液泡膜蛋白 1、红细胞生成素相关因子 2、钠-葡萄糖共转运蛋白 2 抑制剂、免疫相关 GTP 酶 M 和自噬相关基因 7 已被报道可通过诱导自噬来改善 MAFLD。脂质受体 CD36、SARS-CoV-2 Spike 蛋白和亮氨酸氨肽酶 3 在自噬功能中起负向作用。本综述总结了自噬在 MAFLD 中的作用的最新进展。自噬调节主要的病理变化,包括肝脂质代谢、炎症和纤维化,提示调节自噬可能成为治疗 MAFLD 的一种方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/9456355/01c5153f9e81/ijms-23-10055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/9456355/efa79034656d/ijms-23-10055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/9456355/01c5153f9e81/ijms-23-10055-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/9456355/efa79034656d/ijms-23-10055-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a2a/9456355/01c5153f9e81/ijms-23-10055-g002.jpg

相似文献

1
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target.代谢相关性脂肪性肝病中自噬失调:一个新的治疗靶点。
Int J Mol Sci. 2022 Sep 2;23(17):10055. doi: 10.3390/ijms231710055.
2
The ménage à trois of autophagy, lipid droplets and liver disease.自噬、脂滴与肝脏疾病的三者关系。
Autophagy. 2022 Jan;18(1):50-72. doi: 10.1080/15548627.2021.1895658. Epub 2021 Apr 2.
3
White adipose tissue in metabolic associated fatty liver disease.代谢相关脂肪性肝病中的白色脂肪组织。
Clin Res Hepatol Gastroenterol. 2024 May;48(5):102336. doi: 10.1016/j.clinre.2024.102336. Epub 2024 Apr 10.
4
A new NRF2 activator for the treatment of human metabolic dysfunction-associated fatty liver disease.一种用于治疗人类代谢功能障碍相关脂肪性肝病的新型NRF2激活剂。
JHEP Rep. 2023 Jul 12;5(10):100845. doi: 10.1016/j.jhepr.2023.100845. eCollection 2023 Oct.
5
Autophagy in liver diseases: Time for translation?肝脏疾病中的自噬:是否到了转化的时机?
J Hepatol. 2019 May;70(5):985-998. doi: 10.1016/j.jhep.2019.01.026. Epub 2019 Jan 31.
6
Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy. Phillygenin 通过 TFEB 介导的溶酶体生物发生和脂噬改善非酒精性脂肪性肝病。
Phytomedicine. 2022 Aug;103:154235. doi: 10.1016/j.phymed.2022.154235. Epub 2022 Jun 3.
7
Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases.甲状腺激素触发自噬在肝脏相关疾病中的分子功能和临床影响。
J Biomed Sci. 2019 Mar 8;26(1):24. doi: 10.1186/s12929-019-0517-x.
8
Role of the mTOR-autophagy-ER stress pathway in high fructose-induced metabolic-associated fatty liver disease.mTOR 自噬-内质网应激通路在高果糖诱导的代谢相关性脂肪性肝病中的作用。
Acta Pharmacol Sin. 2022 Jan;43(1):10-14. doi: 10.1038/s41401-021-00629-0. Epub 2021 Mar 17.
9
Autophagy and Lipid Droplets in the Liver.肝脏中的自噬与脂滴
Annu Rev Nutr. 2015;35:215-37. doi: 10.1146/annurev-nutr-071813-105336. Epub 2015 May 6.
10
Therapeutic regulation of autophagy in hepatic metabolism.肝脏代谢中自噬的治疗性调节
Acta Pharm Sin B. 2022 Jan;12(1):33-49. doi: 10.1016/j.apsb.2021.07.021. Epub 2021 Jul 28.

引用本文的文献

1
Multi-omics reveals total flavones from Abelmoschus manihot (L.) Medik. [Malvaceae] ameliorate MAFLD via PI3K/AKT/mTOR-mediated autophagy.多组学研究揭示了锦葵科苘麻中的总黄酮通过PI3K/AKT/mTOR介导的自噬改善代谢相关脂肪性肝病。
Front Pharmacol. 2025 Jul 11;16:1601707. doi: 10.3389/fphar.2025.1601707. eCollection 2025.
2
Loss of hepatic autophagy induces α-cell proliferation through impaired glutamine-dependent gluconeogenesis.肝脏自噬的丧失通过受损的谷氨酰胺依赖性糖异生诱导α细胞增殖。
Physiol Rep. 2025 May;13(10):e70381. doi: 10.14814/phy2.70381.
3
Unveiling p65 as the target of diphyllin in ameliorating metabolic dysfunction-associated steatotic liver disease via targeted protein degradation technology.

本文引用的文献

1
Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1-Adiponectin Axis.恩格列净通过 HO-1-脂联素轴减轻肥胖相关的肾脏功能障碍和 NLRP3 炎症小体活性。
Front Endocrinol (Lausanne). 2022 Jun 17;13:907984. doi: 10.3389/fendo.2022.907984. eCollection 2022.
2
The Spike Protein of SARS-CoV-2 Impairs Lipid Metabolism and Increases Susceptibility to Lipotoxicity: Implication for a Role of Nrf2.SARS-CoV-2 的刺突蛋白会损害脂代谢,并增加脂肪毒性易感性:对 Nrf2 作用的提示。
Cells. 2022 Jun 14;11(12):1916. doi: 10.3390/cells11121916.
3
TSC22D4 promotes TGFβ1-induced activation of hepatic stellate cells.
通过靶向蛋白质降解技术揭示p65作为双叶豆素改善代谢功能障碍相关脂肪性肝病的靶点。
Front Pharmacol. 2025 Apr 28;16:1567639. doi: 10.3389/fphar.2025.1567639. eCollection 2025.
4
Fluorofenidone attenuates choline-deficient, l-amino acid-defined, high-fat diet-induced metabolic dysfunction-associated steatohepatitis in mice.氟非尼酮减轻胆碱缺乏、L-氨基酸限定、高脂饮食诱导的小鼠代谢功能障碍相关脂肪性肝炎。
Sci Rep. 2025 Mar 21;15(1):9863. doi: 10.1038/s41598-025-94401-7.
5
Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis.自噬与过氧化物酶体增殖物激活受体信号通路:脂质代谢与体内平衡中的分子芭蕾。
Mol Cell Biochem. 2025 Jun;480(6):3477-3499. doi: 10.1007/s11010-025-05207-0. Epub 2025 Feb 1.
6
Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways.神经调节蛋白1通过ERK/SIRT1信号通路改善代谢功能障碍相关脂肪性肝病。
BMC Gastroenterol. 2025 Jan 30;25(1):47. doi: 10.1186/s12876-025-03632-5.
7
Protective Effect of Modified Suanmei-Tang on Metabolic-Associated Fatty Liver Disease: An Integrated Strategy of Network Pharmacology, Metabolomics, and Transcriptomics.酸梅汤改良方防治代谢相关性脂肪性肝病的作用:网络药理学、代谢组学和转录组学的综合策略。
Drug Des Devel Ther. 2024 Nov 13;18:5161-5182. doi: 10.2147/DDDT.S478072. eCollection 2024.
8
The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease.自噬失调在非酒精性脂肪性肝病进展中的关键作用。
Front Endocrinol (Lausanne). 2024 Aug 8;15:1374644. doi: 10.3389/fendo.2024.1374644. eCollection 2024.
9
Autophagy and hepatic lipid metabolism: mechanistic insight and therapeutic potential for MASLD.自噬与肝脏脂质代谢:非酒精性脂肪性肝病的机制洞察与治疗潜力
NPJ Metab Health Dis. 2024;2(1):19. doi: 10.1038/s44324-024-00022-5. Epub 2024 Aug 2.
10
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?儿童肥胖中的代谢功能障碍相关脂肪性肝病(MAFLD)与甲状腺功能:恶性循环?
Children (Basel). 2024 Feb 15;11(2):244. doi: 10.3390/children11020244.
TSC22D4 促进 TGFβ1 诱导的肝星状细胞激活。
Biochem Biophys Res Commun. 2022 Aug 27;618:46-53. doi: 10.1016/j.bbrc.2022.05.100. Epub 2022 Jun 9.
4
Immunity-related GTPase IRGM at the intersection of autophagy, inflammation, and tumorigenesis.免疫相关 GTPase IRGM 在自噬、炎症和肿瘤发生中的作用。
Inflamm Res. 2022 Aug;71(7-8):785-795. doi: 10.1007/s00011-022-01595-x. Epub 2022 Jun 14.
5
Targeting Nrf2 in ischemia-reperfusion alleviation: From signaling networks to therapeutic targeting.针对缺血再灌注缓解中的 Nrf2:从信号网络到治疗靶点。
Life Sci. 2022 Jul 1;300:120561. doi: 10.1016/j.lfs.2022.120561. Epub 2022 Apr 20.
6
Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis.缺乏 VMP1 会损害肝脏脂蛋白的分泌并促进非酒精性脂肪性肝炎。
J Hepatol. 2022 Sep;77(3):619-631. doi: 10.1016/j.jhep.2022.04.010. Epub 2022 Apr 19.
7
The Role of Hydrogen Sulfide Regulation of Autophagy in Liver Disorders.硫化氢调控自噬在肝疾病中的作用
Int J Mol Sci. 2022 Apr 6;23(7):4035. doi: 10.3390/ijms23074035.
8
Rare ATG7 genetic variants predispose patients to severe fatty liver disease.罕见的 ATG7 基因突变使患者易患严重的脂肪肝疾病。
J Hepatol. 2022 Sep;77(3):596-606. doi: 10.1016/j.jhep.2022.03.031. Epub 2022 Apr 9.
9
Cholesterol-induced leucine aminopeptidase 3 (LAP3) upregulation inhibits cell autophagy in pathogenesis of NAFLD.胆固醇诱导亮氨酸氨肽酶 3(LAP3)上调抑制 NAFLD 发病机制中的细胞自噬。
Aging (Albany NY). 2022 Apr 11;14(7):3259-3275. doi: 10.18632/aging.204011.
10
Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence.褪黑素对肝纤维化的有益作用:当前生物学证据的系统评价。
J Cell Physiol. 2022 Jul;237(7):2740-2757. doi: 10.1002/jcp.30735. Epub 2022 Apr 11.